Table 1.
Definition and Criteria for AKI Stages | Modifications |
---|---|
pRIFLE | |
Stage 1 (Risk): eGFR decreased by 25% | |
Stage 2 (Injury): eGFR decreased by 50% | |
Stage 3 (Failure): eGFR decrease by 75% | |
or | |
eGFR <35 ml/min per 1.73 m2 | |
AKIN | |
Stage 1: Increase in creatinine of ≥50% | 0.3-mg/dl increase added to stage 1 |
or | AKI diagnosed over 48-hr period |
Absolute increase in creatinine of 0.3 mg/dl | |
Stage 2: Increase in creatinine of ≥100% | |
Stage 3: Increase in creatinine of ≥200% | |
KDIGO | |
Stage 1: Increase in creatinine of ≥50% | eGFR threshold from pRIFLE added to stage 3 |
or | Creatinine changes (except absolute 0.3-mg/dl increase) required to occur within a 7-d time frame |
Absolute increase in creatinine of 0.3 mg/dl | |
Stage 2: Increase in creatinine of ≥100% | |
Stage 3: Increase in creatinine of ≥200% | |
or | |
eGFR ≤35 ml/min per 1.73 m2 (if age <18 yr) |
eGFR was estimated using the Schwartz method. pRIFLE, pediatric RIFLE; AKIN, Acute Kidney Injury Network; KDIGO, Kidney Diseases Improving Global Outcomes.